All eyes are on the preliminary data Moderna is preparing to submit to the monitoring board on its vaccine candidate's effectiveness, which works on technology similar to Pfizer's.
The candidate is a so-called messenger RNA vaccine, based on technology similar to that used by one of the fastest-moving vaccine developers, Moderna Inc.
Moderna decided to make the declaration because investors had started noticing that the company has patents that might apply to other Covid vaccines, says its president.
The vaccine, called mRNA-1273, is being developed by Moderna with the US govt's National Institutes of Health. The small study involved 40 adults aged over 56.
The results from Moderna’s early-stage trial, which include data from 20 participants, are important because older adults often don’t respond as well to vaccines as younger adults.
‘Mother kept pouring water in our eyes whenever the burning became unbearable. She pushed our bodies deep into the blanket, making sure not a single part was exposed,’ my father said.
December oil imports from Russia may drop nearly 50%, but Indian buyers already shifting to non-designated Russian entities and opaque trading channels to keep Russian oil flowing.
The helicopters produced by Lockheed Martin are known as ‘submarine hunters’. India ordered 24 of these aircraft in 2020 to replace the Sea King helicopters. 15 have been delivered till date.
The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.
COMMENTS